Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Issues New Technical Guidelines For Medical Devices In Preparation For Healthcare Reform

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State FDA released April 28 six new technical guidelines for medical device registration that will prepare local industry for the increase in device registration anticipated by China's booming healthcare reforms

You may also be interested in...



China Establishes New Center To Improve Quality Control For Medical Devices

SHANGHAI - China's State FDA recently unveiled its new Management Center for Medical Devices Standards in Beijing to oversee the drafting and revision of device standards

China Establishes New Center To Improve Quality Control For Medical Devices

SHANGHAI - China's State FDA recently unveiled its new Management Center for Medical Devices Standards in Beijing to oversee the drafting and revision of device standards

China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009

SHANGHAI - China's Central government announced it would invest RMB 118.1 billion ($17.3 billion) for healthcare reform in 2009 during a joint working meeting April 20 with the National Development and Reform Committee, the Ministry of Health, the Ministry Of Finance, the Ministry of Human Resources and Social Security and the State FDA

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel